GGrantIndex
Sort

23,748 grants matching melanoma

Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma

$247,713
Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Project 2: Analysis of non-cell autonomous heterotypic and homotypic cell-cell interaction in invasive cancer models

$247,705
Gunter P. Wagner · Yale University · U54 · FY2020 · CA

Experimental Therapeutics

$247,662
Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2013 · CA

ARF6 function in cancers driven by RAS hyperactivation

$247,551
Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2022 · CA

ARF6 function in cancers driven by RAS hyperactivation

$247,551
Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2023 · CA

Molecular and Cellular Analysis of Allograft Loss in Kidney Transplant Biopsies

$247,531
Casey R Dorr · Hennepin Healthcare Research Institute · R21 · FY2022 · AI

ENGINEERING T CELLS FOR PANCREATIC CANCER

$247,486
Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA

CHEMOKINE RECEPTOR STUDIES

$247,447
Vanderbilt University · R01 · FY2001 · CA

Hypoxia induces SHMT2 to regulate cellular redox and epigenetics

$247,424
Jiangbin Ye · Stanford University · R00 · FY2017 · CA

Hypoxia induces SHMT2 to regulate cellular redox and epigenetics

$247,424
Jiangbin Ye · Stanford University · R00 · FY2019 · CA

A novel cellular tumor vaccine strategy for mutant IDH1 glioma

$247,407
Michael D Gunn · Duke University · P50 · FY2019 · CA

Core 2: Biospecimen Core

$247,382
Ruth Halaban · Yale University · P50 · FY2022 · CA

IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS

$247,378
Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA

DEVELOPMENTAL RESEARCH PROGRAM

$247,372
Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2008 · CA

GENE THERAPY FOR HUMAN MALIGNANT MELANOMA

$247,353
Introgen Therapeutics, Inc. · R41 · FY2001 · CA

A High-Throughput Model for Human Melanoma

$247,340
Sheri L. Holmen · University Of Utah · R01 · FY2016 · CA

A High-Throughput Model for Human Melanoma

$247,340
Sheri L. Holmen · University Of Utah · R01 · FY2017 · CA

A High-Throughput Model for Human Melanoma

$247,340
Sheri L. Holmen · University Of Utah · R01 · FY2018 · CA

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

$247,329
Levi Alexander Garraway · Dana-Farber Cancer Inst · P50 · FY2015 · CA

Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment

$247,327
Judy K Brunso-Bechtold · Wake Forest University Health Sciences · R01 · FY2009 · CA

Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment

$247,327
Judy K Brunso-Bechtold · Wake Forest University Health Sciences · R01 · FY2008 · CA

Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment

$247,327
Judy K Brunso-Bechtold · Wake Forest University Health Sciences · R01 · FY2007 · CA

Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment

$247,327
Michael E.c. Robbins · Wake Forest University Health Sciences · R01 · FY2010 · CA

Optimization of Melanoma Vaccines with T-Helper Epitopes

$247,310
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA

Inhibition of Cytochrome c-induced Caspase Activation

$247,272
Sally A Kornbluth · Duke University · R01 · FY2013 · CA